Skip to main content
Figure 4 | BMC Urology

Figure 4

From: Urinary levels of Hepatocarcinoma-intestine-pancreas/Pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer

Figure 4

Urinary HIP/PAP levels in relation to recurrence-risk and progression-risk classifications of non-muscle invasive BCa. (A) Urinary levels were significantly higher in the intermediate risk group than in the low recurrence-risk group of non-muscle invasive BCa (Mann–Whitney U test, P = 0.0002). (B) Urinary HIP/PAP levels correlated significantly with increased risk of progression in non-muscle invasive BCa cases (Kruskal-Wallis test, P = 0.0008).

Back to article page